Skip to content
10-K

Annual Report

AIFARM, LTD.

0001654954-20-005507

← back to feed
Filed
May 14, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 14, 2020 0 sh
Operating Cash Flow FY 2019 · Dec 31, 2019 −$590.9K
Operating Cash Flow FY 2019 · Dec 31, 2018 −$1.41M
Stockholders Equity FY 2019 · Dec 31, 2019 −$1.85M
Stockholders Equity FY 2019 · Dec 31, 2018 −$1.95M
Total Liabilities FY 2019 · Dec 31, 2019 $3.48M
Total Liabilities FY 2019 · Dec 31, 2018 $3.59M
Total Assets FY 2019 · Dec 31, 2019 $88.27K
Total Assets FY 2019 · Dec 31, 2018 $97.12K
Sga Expense FY 2019 · Dec 31, 2019 −$487.13K
Sga Expense FY 2019 · Dec 31, 2018 −$85.3K
Net Income FY 2019 · Dec 31, 2019 −$547.1K
Net Income FY 2019 · Dec 31, 2018 −$110.58K
Operating Income FY 2019 · Dec 31, 2019 −$487.13K
Operating Income restated FY 2019 · Dec 31, 2018 −$85.3K